Alembic Pharmaceuticals informs about company updates

28 Jan 2020 Evaluate
Alembic Pharmaceuticals has informed that the company has received US Food & Drug Administration (USFDA) Final approval for Azithromycin Tablets USP, 600 mg. The company has enclosed its press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

770.20 -5.10 (-0.66%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×